These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16904420)

  • 1. Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception.
    Blumenthal PD; Trussell J; Singh RH; Guo A; Borenstein J; Dubois RW; Liu Z
    Contraception; 2006 Sep; 74(3):249-58. PubMed ID: 16904420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of treatments for dysfunctional uterine bleeding.
    Wade SW; Magee G; Metz L; Broder MS
    J Reprod Med; 2006 Jul; 51(7):553-62. PubMed ID: 16913546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Brown PM; Farquhar CM; Lethaby A; Sadler LC; Johnson NP
    BJOG; 2006 Jul; 113(7):797-803. PubMed ID: 16827763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
    Ganz ML; Shah D; Gidwani R; Filonenko A; Su W; Pocoski J; Law A
    Value Health; 2013; 16(2):325-33. PubMed ID: 23538185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain.
    Lete I; Cristóbal I; Febrer L; Crespo C; Arbat A; Hernández FJ; Brosa M
    Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):71-80. PubMed ID: 20951492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States.
    Ashraf T; Arnold SB; Maxfield M
    J Reprod Med; 1994 Oct; 39(10):791-8. PubMed ID: 7837126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study.
    Suhonen S; Haukkamaa M; Jakobsson T; Rauramo I
    Contraception; 2004 May; 69(5):407-12. PubMed ID: 15105064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.
    Trussell J; Hassan F; Henry N; Pocoski J; Law A; Filonenko A
    Contraception; 2014 May; 89(5):451-9. PubMed ID: 24576791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
    Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
    Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
    Milsom I
    Contraception; 2007 Jun; 75(6 Suppl):S152-4. PubMed ID: 17531608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing drug-resistant essential menorrhagia without hysterectomy.
    Hurskainen R
    Best Pract Res Clin Obstet Gynaecol; 2006 Oct; 20(5):681-94. PubMed ID: 16731045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire.
    Radesic B; Sharma A
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.